Sign in

AKAN on Nasdaq

AKANDA CORP.

AKANDA CORP. is a Canadian medicinal chemicals and botanical products company based in New Romney.2

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Adia Med, Inc., TFA Therapeutics, Inc. or China Foods Holdings Ltd., or pick any stock.

  • TickerAKAN on Nasdaq2
  • IndustryMedicinal Chemicals & Botanical Products2
  • HeadquartersToronto, Canada2
  • Incorporated inOntario, Canada3
  • Business address1A, 1B Learoyd Road, New Romney, X0 Tn28 8Xu3
  • Filer category, Emerging growth company3
  • Legal formCorporation2
  • LEI549300WWGNIP0LEI83242
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered address77 King Street West, M5K 0A1 Toronto, Canada2
  • Registered withMinistry of Government and Consumer Services, 28546182

See how the biggest companies compare on our leaderboards

Holigen Acquisition, Akanda purchased 14,285,714 Common Shares of Flowr for an aggregate purchase price of CAD$999,999.98.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

24.9%Gross margin5
-523.8%Operating margin5
-489.6%Net margin5
97.5%Revenue growth, 20245
-95.8%Return on equity5
-$6.1MFree cash flow5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Infrastructure brought in 50% of the revenue AKANDA CORP. broke down this way in fiscal 2025.

  1. Infrastructure$258.1K650%
  2. Reportable segments [member]$258.1K650%
Business segments by year
Business segments2025
Infrastructure$258.1K
Reportable segments [member]$258.1K

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue75¢$628.3K
  • Other costs13¢$108.3K
  • Interest12¢$100.1K

Out of $836.7K in revenue.5 The company lost money this year.

Financial statements

Revenue785$836.7K in 2024+40475% since 2020
0$1.0M$2.0M$3.0M2020: $2.1K$2.1K20202021: $41.4K$41.4K2021+1909%2022: $2.6M$2.6M2022+6223%2023: $423.7K$423.7K2023−84%2024: $836.7K$836.7K2024+97%
Gross profit785$208.4K in 2024
-$1.0M0$1.0M$2.0M$3.0M$4.0M2020: -$58.2K-$58.2K20202021: -$1.6K-$1.6K2021−97%2022: $3.3M$3.3M20222023: $59.3K$59.3K2023−98%2024: $208.4K$208.4K2024+251%
Operating income785-$4.4M in 2024+386% since 2019
-$30.0M-$20.0M-$10.0M02019: -$901.2K-$901.2K20192020: -$1.7M-$1.7M2020+85%2021: -$2.6M-$2.6M2021+54%2022: -$20.2M-$20.2M2022+685%2023: -$3.7M-$3.7M2023−82%2024: -$4.4M-$4.4M2024+20%
Net income785-$4.1M in 2024+194% since 2019
-$40.0M-$30.0M-$20.0M-$10.0M02019: -$1.4M-$1.4M20192020: -$2.3M-$2.3M2020+65%2021: -$8.1M-$8.1M2021+253%2022: -$11.7M-$11.7M2022+43%2023: -$32.3M-$32.3M2023+177%2024: -$4.1M-$4.1M2024−87%

Every line of the income statement as filed: the last 2 fiscal years, latest first.6

Period ending2025-12-312024-12-31
Sales$258.1K
Cost of sales$414.1K
Gross Profit (Loss)-$156.0K
Depreciation and amortization$433.7K$137.3K
Consulting and professional fees$1.5M$2.4M
Personnel expenses$624.7K$495.7K
General and administrative expenses$2.3M$1.0M
Total operating expenses$4.8M$4.0M
Operating loss-$5.0M-$4.0M
Finance income$3.0K
Finance expense-$925.1K-$81.1K
Foreign exchange gain (loss), net$273.6K-$132.8K
Transaction costs-$350.0K
Change in fair value of financial liabilities measured at FVTPL$1.8M
Gain (loss) on debt settlement$1.9M-$219.7K
Other income$74.5K
Gain on sale of subsidiary$198.8K
Write-off of AP, net$475.8K
Write-off of holdback payable$400.0K
Write-off of loan receivable-$235.7K
Impairment loss-$44.8M
Total Other income-$42.4M$718.4K
Net loss from continuing operations-$47.4M-$3.3M
Gain (loss) from discontinued operation$507.6K-$784.2K
Net loss-$46.9M-$4.1M
Translation adjustment-$175.7K-$101.2K
Shareholders of the Company-$45.7M-$4.1M
Non-controlling interest-$1.2M
Shareholders of the Company-$46.2M-$4.2M
Non-controlling interest-$792.7K
Net comprehensive loss attributable-$47.0M-$4.2M
Loss per share from continuing operations basic (in Dollars per share)-$669.58-$223.48
Loss per share from continuing operations diluted (in Dollars per share)-$669.58-$223.48
Loss per share basic (in Dollars per share)-$662.22-$276.40
Loss per share diluted (in Dollars per share)-$662.22-$276.40
Weighted average common shares outstanding (in Shares)68.9K shares14.8K shares

Compare AKANDA CORP. with another company

Corporate structure

AKANDA CORP. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of AKANDA CORP.

  • Halo Collective Inc. Filed SC 13D/A on AKANDA CORP., latest Feb 20, 2024 (4 filings since Feb 15, 2023)
  • Wilson Su Filed SC 13G on AKANDA CORP., latest Oct 25, 2023
  • 1306077 B.C. Ltd. Filed SC 13G on AKANDA CORP., latest Jan 9, 2023
  • AKANDA CORP. Toronto, Ontario, Canada

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What AKANDA CORP. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$2.3M5 Dec 31, 2024$2.5M5 Dec 31, 2023−7.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$3.8M5 Dec 31, 2024$93.9K5 Dec 31, 2023+3992.5%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$15.8K5 Dec 31, 2024$3.8M5 Dec 31, 2023−99.6%

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Chairman and director of Akanda Corp.Louisa Mojela named Nov 29, 20219
  • Chief Executive Officer and Director of Akanda Corp.Tejinder Virk named Nov 29, 20219
  • Chief Financial Officer and Corporate Secretary of Akanda Corp.Trevor Scott named Nov 29, 20219
  • Lead Independent Director of Akanda Corp.Charles Kie named Nov 29, 20219

Timeline

  1. Mar 17, 2022Founded AKANDA CORP. is founded2

Filings

198 filings to the SEC since October 2021: 5 annual reports, 2 insider forms, 6 large holders, 1 private raises, 184 other. The latest 20:

  1. Oct 1, 2026F-1 REGISTRATION STATEMENT EDGAR
  2. Sep 30, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  3. Sep 25, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  4. Sep 9, 20266-K EDGAR
  5. Sep 4, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  6. Aug 17, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  7. Aug 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  8. Jun 18, 20266-K EDGAR
  9. Jun 12, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  10. Jun 9, 202620-F ANNUAL REPORT EDGAR
  11. May 22, 20266-K CURRENT REPORT EDGAR
  12. May 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  13. May 1, 2026NT 20-F NOTIFICATION OF LATE FILING EDGAR
  14. Apr 29, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  15. Apr 10, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  16. Apr 9, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  17. Apr 7, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  18. Apr 2, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  19. Mar 31, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  20. Mar 20, 2026F-1/A AMENDMENT NO. 3 TO FORM F-1 EDGAR

The 198 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

2 open-market trades by officers, directors and large owners since October 2021: 1 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 16, 2026HRT FINANCIAL LP10% ownerSale7,868$1.29$10.2KForm 4
Jan 15, 2026HRT FINANCIAL LP10% ownerBuy29,036$1.40$40.6KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$1.8M 2021–2021
Money received by yearMoney received by year, 2021–2021: $1.8M in all. Private raises (Form D) $1.8M.$0$500K$1M$1.5M$2M2021 · Private raises (Form D): $1.8M2021
Figures by year
YearPrivate raises (Form D)Total
2021$1.8M$1.8M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Nov 12, 2021Raised $1.8 million in a private offering of equity9 Form D: $10 million offered in all Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Integrated Wealth Concepts LLC600$8.2K0.0%New
UBS Group AG205$2.8K0.0%New
Wells Fargo & Company/mn13$1780.0%New
Morgan Stanley2$270.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How AKANDA CORP. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAKANDA CORP.1
  • CIK0001888014
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company4
  • Incorporated inCanada4
  • Fiscal year endsDecember 311
  • Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address1A, 1B Learoyd Road, New Romney, X0 TN28 8XU1
  • Mailing address77 King Street West, Suite 400, C/O Dentons Canada Llp, Toronto, A6 M5K 0A11
  • Phone4420348895141
  • Shares outstanding1,983,546 shares as of Dec 31, 20254
  • AuditorGreenGrowthCPAs, Los Angeles, California PCAOB ID 6580; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceNov 19, 20211
  • Filings198 in all: 6-K (119), CORRESP (15), F-1/A (8), F-1 (6), 20-F (5), 424B3 (5), 424B5 (5), EFFECT (5)1
    All 24 form types

    UPLOAD (5), S-8 (4), 424B4 (3), NT 20-F (3), SC 13G (3), 144 (2), 3 (1), 4 (1), 8-A12B (1), CERT (1), D (1), DRS (1), F-3 (1), SC 13D (1), SC 13D/A (1), SC 13G/A (1)

  • Latest filingsAnnual report (20-F) Jun 9, 2026

Securities registered for trading

ClassSymbolExchange
Common SharesAKANNasdaq

From the cover page of the 20-F filed Jun 9, 2026 (Section 12(b) of the Exchange Act).4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12